Opportunity Information: Apply for PAR 21 218

The NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) (Funding Opportunity Number PAR-21-218) is a National Institutes of Health training-focused grant designed to strengthen and diversify the pipeline of translational researchers working on Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The central aim is workforce development: supporting promising predoctoral students from diverse backgrounds so they can build the practical translational skill sets that are increasingly essential for moving discoveries from basic research into real-world tools for prevention, detection, treatment, and care. The National Institute on Aging (NIA) is using this fellowship mechanism to help trainees become prepared not just for individual projects, but for the broader, collaborative work style that dominates modern translational science.

A distinctive emphasis of this FOA is the intentional focus on data science and drug discovery, and on applying those approaches across the full spectrum of AD/ADRD research. In practice, that means the fellowship can support training and research experiences ranging from population and epidemiologic studies to work that informs new therapeutics and diagnostics, and it explicitly includes behavioral and social research as part of the AD/ADRD landscape. The fellowship is meant to help predoctoral researchers gain "translational" capabilities, such as working with complex datasets, developing or applying computational methods, and understanding elements of discovery and development pathways that can eventually lead to interventions. The long-term vision is to build a diverse translational workforce capable of contributing to, and in many cases leading, team-science and precision-medicine approaches to AD/ADRD, including treatment, prevention, early detection, disease management, and care.

The opportunity is classified as a discretionary grant under the health funding activity category (CFDA 93.866) and is offered by the National Institutes of Health. Eligibility is broad at the organizational level and includes many common public and private applicant types, such as public and state-controlled institutions of higher education and private institutions of higher education, state and local governments (including counties, cities/townships, special districts, and independent school districts), federally recognized Native American tribal governments, public housing authorities/Indian housing authorities, nonprofit organizations with or without 501(c)(3) status (outside of higher education), for-profit organizations (other than small businesses), and small businesses. The FOA also calls out additional eligible applicant categories that reflect a strong commitment to capacity-building in institutions and communities historically underrepresented in biomedical research, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also notes eligibility for faith-based or community-based organizations, regional organizations, U.S. territories or possessions, eligible federal agencies, and Indian/Native American tribal governments that are not federally recognized.

The FOA includes important restrictions related to foreign participation. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply as applicant organizations. In addition, non-domestic components of U.S. organizations are not eligible to apply. However, the announcement specifies that "foreign components," as defined in the NIH Grants Policy Statement, are allowed, which generally means that certain parts of the research or training experience may occur outside the U.S. under NIH rules when appropriately justified and structured, even though the applicant organization itself must be domestic.

Key administrative details from the source information include the FOA title noted above, the NIH as the funding agency, and an original closing date listed as 2024-08-08. The award ceiling and the number of expected awards are not provided in the supplied source fields, which is common in some listings and typically means applicants should consult the full FOA text and NIH policy pages for current stipend levels, institutional allowance information, and budget structure specific to the F31 fellowship mechanism. Overall, this opportunity is best understood as a targeted predoctoral fellowship program intended to expand who participates in AD/ADRD translational research and to ensure trainees emerge with modern, high-impact skills in data science and drug discovery that can accelerate progress toward better outcomes for people affected by dementia.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2021-05-28.
  • Applicants must submit their applications by 2024-08-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 21 218

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)

Previous opportunity: Cooperative Agreement for CESU - Great Lakes – Northern Forest Cooperative Ecosystem Studies Unit

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 21 218

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 21 218) also looked into and applied for these:

Funding Opportunity
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Resource (U24 Clinical Trial Not Allowed) Apply for RFA AA 21 012

Funding Number: RFA AA 21 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional) Apply for RFA AA 21 014

Funding Number: RFA AA 21 014
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Resource (U24 Clinical Trial Not Allowed) Apply for RFA AA 21 013

Funding Number: RFA AA 21 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Resource (U24) (Clinical Trial Not Allowed) Apply for RFA AA 21 011

Funding Number: RFA AA 21 011
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional) Apply for RFA AA 21 010

Funding Number: RFA AA 21 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed) Apply for RFA HG 21 026

Funding Number: RFA HG 21 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 21 017

Funding Number: RFA RM 21 017
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Shared Personal Protective Equipment (PPE) Resources (S10 Clinical Trial Not Allowed) Apply for PAR 21 257

Funding Number: PAR 21 257
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed) Apply for RFA RM 21 023

Funding Number: RFA RM 21 023
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Large Research Projects for Prevention of Healthcare-Associated Infections (R01) Apply for PA 21 265

Funding Number: PA 21 265
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 019

Funding Number: RFA AG 22 019
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 046

Funding Number: RFA AI 21 046
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 22 014

Funding Number: RFA AG 22 014
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) Apply for RFA AG 22 004

Funding Number: RFA AG 22 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) Apply for RFA AG 22 007

Funding Number: RFA AG 22 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed) Apply for RFA AG 22 003

Funding Number: RFA AG 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) Apply for PAR 21 240

Funding Number: PAR 21 240
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 21 243

Funding Number: PAR 21 243
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) Apply for PAR 21 242

Funding Number: PAR 21 242
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) Apply for PAR 21 241

Funding Number: PAR 21 241
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 218", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: